Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 3
1950 4
1951 7
1952 3
1953 2
1954 1
1955 6
1956 7
1957 2
1958 4
1959 5
1960 2
1961 2
1963 1
1966 2
1967 2
1968 1
1970 2
1971 1
1974 2
1975 1
1977 3
1978 4
1979 2
1980 4
1981 5
1982 5
1983 5
1984 6
1985 3
1986 11
1987 6
1988 7
1989 19
1990 9
1991 6
1992 14
1993 5
1994 7
1995 8
1996 13
1997 12
1998 11
1999 8
2000 7
2001 6
2002 5
2003 1
2004 4
2005 1
2006 9
2007 6
2008 4
2009 7
2010 8
2011 5
2012 6
2013 14
2014 11
2015 8
2016 9
2017 16
2018 18
2019 12
2020 25
2021 22
2022 23
2023 23
2024 29
2025 33
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

507 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, Niu T, Weinstock T, Ratjen F, Rosenfeld M. Goralski JL, et al. Among authors: hoppe je. Am J Respir Crit Care Med. 2023 Jul 1;208(1):59-67. doi: 10.1164/rccm.202301-0084OC. Am J Respir Crit Care Med. 2023. PMID: 36921081 Free PMC article.
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
Hoppe JE, Kasi AS, Pittman JE, Jensen R, Thia LP, Robinson P, Tirakitsoontorn P, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Salinas DB, Zhu J, Chen YC, Rodriguez-Romero V, Sosnay PR, Davies G; VX21-121-105 Study Group. Hoppe JE, et al. Lancet Respir Med. 2025 Mar;13(3):244-255. doi: 10.1016/S2213-2600(24)00407-7. Epub 2025 Jan 2. Lancet Respir Med. 2025. PMID: 39756425 Free PMC article. Clinical Trial.
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease.
Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P, Hering M, Huckenbeck T, Hoppe J, Semleit N, Deister-Jonas J, Zako S, Seel J, Coman C, Barth M, Cramer M, Helten C, Wildeis L, Hu H, Al-Kassis G, Metzen D, Hesse J, Weber J, Dannenberg L, Akhyari P, Lichtenberg A, Quast C, Gerdes N, Zeus T, Borst O, Kelm M, Petzold T, Ahrends R, Levkau B, Polzin A. Benkhoff M, et al. Among authors: hoppe j. Circulation. 2025 Jan 28;151(4):333-347. doi: 10.1161/CIRCULATIONAHA.123.067270. Epub 2024 Oct 21. Circulation. 2025. PMID: 39429140
Neonatal pertussis.
Hoppe JE. Hoppe JE. Pediatr Infect Dis J. 2000 Mar;19(3):244-7. doi: 10.1097/00006454-200003000-00014. Pediatr Infect Dis J. 2000. PMID: 10749468 Review. No abstract available.
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis.
Mayer-Hamblett N, Gifford AH, Kloster M, Russell R, Braun AT, Gibson RL, Hoppe JE, Jain R, Linnemann RW, Liou TG, Lysinger J, Milla C, Riekert KA, Sawicki GS, Young J, Nichols D. Mayer-Hamblett N, et al. Among authors: hoppe je. Ann Am Thorac Soc. 2024 Nov;21(11):1507-1515. doi: 10.1513/AnnalsATS.202404-366OC. Ann Am Thorac Soc. 2024. PMID: 39041864 Free PMC article. Clinical Trial.
Provider Reactions to Opioid-Prescribing Report Cards.
Alishahi ML, Olson K, Brooks-Russell A, Hoppe J, Runyan C. Alishahi ML, et al. Among authors: hoppe j. J Public Health Manag Pract. 2022 Mar-Apr 01;28(2):E518-E524. doi: 10.1097/PHH.0000000000001382. J Public Health Manag Pract. 2022. PMID: 34016911
507 results